Established in 2004 by CEO and founder James J. Chen, Agno Pharmaceuticals is a US-headquartered global CDMO with roughly 500 employees. The company is known for helping pharmaceutical and biotech clients move challenging drug programs from development into clinical and commercial production, with particular depth in sterile products and long-acting implants.
ISO 13485:2016
cGMP
Compliance program
FDA-Approved
Compliance program
DEA-Licensed for all Schedules
Compliance program